Astrazeneca (AZN) Equity Average (2016 - 2025)
Astrazeneca (AZN) has 2 years of Equity Average data on record, last reported at $44.8 billion in Q4 2025.
- For Q4 2025, Equity Average rose 11.95% year-over-year to $44.8 billion; the TTM value through Dec 2025 reached $44.8 billion, up 11.95%, while the annual FY2025 figure was $44.8 billion, 11.95% up from the prior year.
- Equity Average reached $44.8 billion in Q4 2025 per AZN's latest filing, up from $40.0 billion in the prior quarter.
- Across five years, Equity Average topped out at $44.8 billion in Q4 2025 and bottomed at $40.0 billion in Q4 2024.